PRLog Free Press Release Distribution + Bookmark This Page
Home| Submit Free Press Release| News Archive| By Category| By Location| By Date| Newsletter| 40,000 RSS Feeds 01:35 AM [GMT -05:00]
 

Filter

Show All Results

Category
Remove Biotech

Country
Remove India

State / Province
Remove Andhra Pradesh

City / Town
(To see all cities,
remove category filter)

Latest News - Biotech - India - Andhra Pradesh

1 - 11 of 11 press releases

Dr Reddys launches Supanac® - (Diclofenac potassium)
2008-01-22, 1091 views - Dr. Reddy's Laboratories Ltd
Dr. Reddy’s has launched Supanac ® (Diclofenac potassium immediate release 50 mg tablets) in India, increasing its offering in the Rs 2700 crores (~ $688 million) NSAID market. (Source: IMS ORG June MAT ’07).

Dr Reddys announces settlement of Exelon ANDA litigation with Novartis
2008-01-22, 580 views - Dr. Reddy's Laboratories Ltd
Dr. Reddy’s announces settlement of Exelon (rivastigmine tartrate) ANDA litigation with Novartis

Argenta Discovery and Dr Reddy’s progress pre-clinical anti-inflammatory candidates
2007-12-20, 232 views - Dr.Reddy's Laboratories Ltd.
Argenta Discovery Limited, the respiratory drug discovery and development company, and Dr Reddy’s Laboratories (NYSE: RDY), today announce a major milestone in their development programme

SYGNIS AG and DR REDDYS Pharmaceutical Company sign exclusive supply collaboration for AX200
2007-12-20, 317 views - Dr.Reddy's Laboratories Ltd.
-- Agreement with Dr. Reddy’s secures long-term supply to advance the clinical development of SYGNIS’ lead product candidate -- -- Dr. Reddy’s first agreement for the long-term supply of a biological molecule; First of its kind from India --

Dr. Reddy's Pharmaceutical Company to release Q2 FY08 results on October 24, 2007
2007-11-15, 209 views - Dr.Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the second quarter ended September 30, 2007 on Wednesday

Dr.Reddy’s Pharmaceutical Company Q2 FY08 revenue at Rs 12,670 million
2007-11-15, 331 views - Dr.Reddy's Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited financial results for the quarter ended September 30, 2007.

First Indian vaccine manufacturer to successfully produce a thimerosal-free Hepatitis B Vaccine
2007-10-30, 1086 views - Bharat Biotech International Limited
A thimerosal-free hepatitis vaccine is preferred choice of pediatricians for birth dose vaccination of new born babies within 12 hours of birth.

BioMinds LifeSciences announces the release of PathoOligoDB(TM), a free qPCR oligos for pathogen.
2007-10-21, 391 views - Biominds LifeSciences Pvt Ltd
PathoOligoDB(TM), a comprehensive database containing extensive information on validated and published qPCR oligos and related resources for pathogen detection. The database is free for academic use.

Dr. Reddy'S Pharmaceutical Company Annual Report on form 20-F for year ended March 31, 2007
2007-10-10, 463 views - Dr.Reddy's Laboratories Ltd
Dr. Reddy’s Laboratories Limited (NYSE: RDY) announces that the company’s annual report on Form 20-F for the year ended March 31, 2007 is available on its website ( http://www.drreddys.com )

Dr. Reddy's Pharmaceutical Company Commences Operations in Philippines.
2007-10-10, 983 views - Dr.Reddy's Pharmaceutical Company
Dr. Reddy's Pharmaceutical Company Commences Operations in Philippines. Expands presence in the ASEAN region

Bharat Biotech announces the Launch of BioHib, India’s First Haemophilus Influenza type b Vaccine
2007-09-04, 388 views - Bharat Biotech International Limited
India’s most pioneering biotech company, Bharat Biotech announces the launch of BioHib, India's first Haemophilus Influenza type b (Hib) vaccine. BioHib is a conjugate vaccine that has proven its safety & efficacy in multi-centric clinical trials.


Page:   1  



How to Write a Press Release| SiteMap| Contact PRLog| Privacy Policy| Terms of Use| Copyright Notice